These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11180129)

  • 1. Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection.
    Santos-Lima EC; Vasconcellos R; Reina-San-Martín B; Fesel C; Cordeiro-Da-Silva A; Berneman A; Cosson A; Coutinho A; Minoprio P
    Eur J Immunol; 2001 Feb; 31(2):634-45. PubMed ID: 11180129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease.
    Minoprio P; Coutinho A; Spinella S; Hontebeyrie-Joskowicz M
    Int Immunol; 1991 May; 3(5):427-33. PubMed ID: 1911532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent.
    Minoprio P; el Cheikh MC; Murphy E; Hontebeyrie-Joskowicz M; Coffman R; Coutinho A; O'Garra A
    J Immunol; 1993 Oct; 151(8):4200-8. PubMed ID: 8409396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V beta 6-bearing T cells are involved in resistance to Trypanosoma cruzi infection in XID mice.
    Cordeiro da Silva A; Lima EC; Vicentelli MH; Minoprio P
    Int Immunol; 1996 Aug; 8(8):1213-9. PubMed ID: 8918690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
    Bryan MA; Guyach SE; Norris KA
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles.
    Powell MR; Wassom DL
    Parasite Immunol; 1993 Apr; 15(4):215-21. PubMed ID: 8506117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.
    Bermejo DA; Amezcua-Vesely MC; Montes CL; Merino MC; Gehrau RC; Cejas H; Acosta-Rodríguez EV; Gruppi A
    PLoS Negl Trop Dis; 2010 May; 4(5):e679. PubMed ID: 20454564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Xid defect imparts susceptibility to experimental murine filariosis--association with a lack of antibody and IL-10 production by B cells in response to phosphorylcholine.
    Al-Qaoud KM; Fleischer B; Hoerauf A
    Int Immunol; 1998 Jan; 10(1):17-25. PubMed ID: 9488152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Repertoires Identify β-Tubulin as a Host Protective Parasite Antigen in Mice Infected With
    Montalvão F; Nascimento DO; Nunes MP; Koeller CM; Morrot A; Lery LMS; Bisch PM; Teixeira SMR; Vasconcellos R; Freire-de-Lima L; Lopes MF; Heise N; DosReis GA; Freire-de-Lima CG
    Front Immunol; 2018; 9():671. PubMed ID: 29706955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi.
    Juri MA; Ferreira A; Ramos A; Hoecker G
    Braz J Med Biol Res; 1990; 23(8):685-95. PubMed ID: 2129269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi in the opossum Didelphis marsupialis: parasitological and serological follow-up of the acute infection.
    Jansen AM; Leon L; Machado GM; da Silva MH; Souza-Leão SM; Deane MP
    Exp Parasitol; 1991 Oct; 73(3):249-59. PubMed ID: 1915740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice.
    de Gaspari EN; Umezawa ES; Zingales B; Stolf AM; Colli W; Abrahamsohn IA
    Mem Inst Oswaldo Cruz; 1990; 85(3):261-70. PubMed ID: 2134701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased immunoglobulin secretion by B lymphocytes from Trypanosoma cruzi infected mice after B lymphocytes-natural killer cell interaction.
    De Arruda Hinds LB; Alexandre-Moreira MS; Decoté-Ricardo D; Nunes MP; Peçanha LM
    Parasite Immunol; 2001 Nov; 23(11):581-6. PubMed ID: 11703809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
    Pereira VR; Lorena VM; Nakazawa M; Luna CF; Silva ED; Ferreira AG; Krieger MA; Goldenberg S; Soares MB; Coutinho EM; Correa-Oliveira R; Gomes YM
    Parasitol Res; 2005 Jun; 96(3):154-61. PubMed ID: 15856302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies.
    el Bouhdidi A; Truyens C; Rivera MT; Bazin H; Carlier Y
    Parasite Immunol; 1994 Feb; 16(2):69-76. PubMed ID: 8015857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies.
    Ternynck T; Bleux C; Gregoire J; Avrameas S; Kanellopoulos-Langevin C
    J Immunol; 1990 Feb; 144(4):1504-11. PubMed ID: 2106000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator.
    Da Silva AC; Espinoza AG; Taibi A; Ouaissi A; Minoprio P
    Immunology; 1998 Jun; 94(2):189-96. PubMed ID: 9741340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect.
    Hitoshi Y; Sonoda E; Kikuchi Y; Yonehara S; Nakauchi H; Takatsu K
    Int Immunol; 1993 Sep; 5(9):1183-90. PubMed ID: 8241057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.